Fundraising Fox
Contera Pharma
Copenhagen, DK · Founded 2010 · 23 employees on LinkedIn · 1 known investors
Find your way into Contera Pharma
Sign up to see every warm intro you have to Contera Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Contera Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bukwang Pharm is a South Korean pharmaceutical company that develops and licenses drugs for antiviral, gastrointestinal, CNS, and metabolic disorders. The company sells primarily licensed products from Europe, the United States, and Japan.
Founders & leadership
TS
Thomas SagerCEOThomas Sager holds a PhD in Neuroscience from the University of Copenhagen and has held management positions at Lundbeck A/S before becoming CEO of Contera Pharma, a clinical-stage RNA medicines company, where he leads strategy and business development including licensing and M&A activities.
JB
John Bondo HansenFounder
MT
Mikael ThomsenFounder
Investors · 1
Related companies · 1
Companies working in the same space as Contera Pharma.
Frequently asked questions
- What does Contera Pharma do?
- Bukwang Pharm is a South Korean pharmaceutical company that develops and licenses drugs for antiviral, gastrointestinal, CNS, and metabolic disorders. The company sells primarily licensed products from Europe, the United States, and Japan.
- Who are Contera Pharma's investors?
- Contera Pharma's investors include SEED Capital Denmark.
- Where is Contera Pharma headquartered?
- Contera Pharma is headquartered in Copenhagen, DK.